These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 20692548

  • 21. The impact of autoimmune disorders and adverse pregnancy outcome.
    Mecacci F, Pieralli A, Bianchi B, Paidas MJ.
    Semin Perinatol; 2007 Aug; 31(4):223-6. PubMed ID: 17825677
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Neurologic complications of immunosuppressive agents.
    Walker RW, Brochstein JA.
    Neurol Clin; 1988 May; 6(2):261-78. PubMed ID: 3138519
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Neonates born from mothers with autoimmune disorders.
    Motta M, Rodriguez-Perez C, Tincani A, Lojacono A, Nacinovich R, Chirico G.
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S67-70. PubMed ID: 19765919
    [Abstract] [Full Text] [Related]

  • 26. How to improve the safety of biologic therapy in Crohn's disease.
    Ferkolj I.
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():67-70. PubMed ID: 20388947
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Monoclonal antibodies in chronic autoimmune inflammatory diseases].
    Semerano L, Boissier MC.
    Med Sci (Paris); 2009 Dec; 25(12):1108-12. PubMed ID: 20035687
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
    Kanzler S, Gerken G, Dienes HP, Meyer zum Büschenfelde KH, Lohse AW.
    Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991
    [Abstract] [Full Text] [Related]

  • 31. [Benefits and risks of treatments used in systemic autoimmune diseases].
    Mouthon L.
    Rev Med Interne; 2008 Jun; 29 Spec No 2():15-23. PubMed ID: 18927989
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Immunosuppressive drug therapy].
    Elonen E.
    Duodecim; 1986 Jun; 102(22):1684-9. PubMed ID: 3803258
    [No Abstract] [Full Text] [Related]

  • 34. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM, Gottlieb AB.
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [Abstract] [Full Text] [Related]

  • 35. Adverse reactions to biologic agents: focus on autoimmune disease therapies.
    Lee SJ, Kavanaugh A.
    J Allergy Clin Immunol; 2005 Oct; 116(4):900-5. PubMed ID: 16210067
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Corticosteroid use in autoimmune blistering diseases.
    Frew JW, Murrell DF.
    Dermatol Clin; 2011 Oct; 29(4):535-44. PubMed ID: 21924995
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Systemic and neurological uses of immunosuppressive agents].
    Schnider C, Seebach JD, Ribi C, Spertini F.
    Rev Med Suisse; 2013 May 01; 9(384):915-21. PubMed ID: 23717900
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.